entertainment -WSS

entertainment

author：focus 2025-09-06 01:59:40 - browse：375

Illustration of a prescription bottle image on the screen of a smart phone – medical tech coverage from STAT — Alex Hogan/STAT

In another sign of the business headwinds facing prescription mental health apps, developer Twill will shop around for a pharmaceutical company to market Aspiro, its cognitive behavioral therapy treatment for both generalized anxiety and major depression.

Twill executives told STAT the company hopes that a drugmaker developing or currently marketing a product for generalized anxiety, or GAD, and major depressive disorder, or MDD, will be interested in adding a digital therapeutic to boost the effect of its drug — as well as its sales. Twill’s chief strategy officer Chris Wasden said that after watching companies built around prescription digital therapeutics, or PDTs, stall out, Twill made the decision earlier this year that it would only take the product to market if it found a willing drugmaker to serve as its partner.

“A PDT is going to be more valuable in the hands of a drug company that has a drug that they would like to get greater adherence [and] greater revenues from rather than trying to get reimbursement for the PDT itself,” he said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： What to know about a major upcoming Wegovy heart health study

focus

hotspot

WSS

How corporate America is slashing DEI workers amid backlash to diversity programs

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Solve the antibiotic resistance crisis with preventive drugs

Medicare reduced heart disease by changing how it pays doctors

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

2023 STAT Wunderkinds: get to know the winners

entertainment

entertainment

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

HHS leader on health, climate change and biopharma emissions

Duchenne breakthrough therapy leaves behind pioneering families

Neutralizing antibodies against HIV shows promise in children

How one medical school became remarkably diverse

STAT Summit: How a Chicago ER doctor tackles gun violence

Trump demands the U.S. pay no more for drugs than other countries … again

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Drug repurposing or repositioning? The language matters

STAT Summit: Biotech founders on deal

Wikipedia

STAT Summit: GSK CEO on pharma giant's new direction

Neutralizing antibodies against HIV shows promise in children

Titanic submersible: What a 'catastrophic implosion' means and what officials found

CEOs share strategies for surviving biotech slump

Will Ozempic

The EU Joint Clinical Assessment needs to live up to its promise

leisure time

focus

hotspot

entertainment